Search results for: 'deaf+teva+and+benchmarking'
- Did you mean
- deal term and benchmarking
-
Dermatology Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Dermatology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Antibiotic Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Antibiotic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Antibody Collaboration and Licensing Deals 2019-2024May 2024$3,995.00Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Autoimmune Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Autoimmune Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Distribution Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00Distribution Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Respiratory Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Respiratory Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2024
Learn More -
Asset Purchase Deals in Pharmaceuticals, Biotechnology, Medical Devices and Diagnostics 2016 to 2024September 2024$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More
